3rd generation glp 1 Comment “Curious” for the deep dive. Retatrutide — a.k.a. “Reta” or “GLP-3” — is being called a future “trillion-dollar drug” and a revolution in fat loss. Retatrutide is a third-generation GLP-1–based drug. ( LY3437943, a novel triple glucagon,

At Brinda Sneha each piece is custom made & handcrafted with exceptional precision & care, designed to offer effortless elegance & comfort

The SURMOUNT-5 trial directly compared the two medications and found tirzepatide produced approximately 20 percent weight loss compared to 14 percent for semaglutide

Its also approved for weight management at higher doses under the brand name Wegovy

J Child Neurol 2003;18:552-4

Moreover, the long-term effects of therapeutic GIP receptor antagonism in humans are not fully elucidated and are thought to depend on the specific drug molecule, receptor functions, and the extent of GLP-1 receptor activation